TITLE

Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease

AUTHOR(S)
Serot, J.-M.; Barbé, F.; Arning, E.; Bottiglieri, T.; Franck, P.; Montagne, P.; Nicolas, J.-P.; Barbé, F
PUB. DATE
November 2005
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Nov2005, Vol. 76 Issue 11, p1585
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Background: Homocysteine may be involved in the pathogenesis of late onset Alzheimer's disease. It is implicated in the metabolism of several important pathways in the brain. Methylmalonic acid (MMA) is related to the metabolism of branched chained amino acids and fatty acids.Objectives: To compare cerebrospinal fluid (CSF) total homocysteine and MMA in elderly subjects, patients with Alzheimer's disease, and younger healthy controls.Subjects: CSF samples were obtained from 33 patients under 20 years of age; 28 patients aged 21 to 60 years; 22 normal elderly subjects aged over 60; and 38 Alzheimer patients aged over 60.Results: CSF total homocysteine increased with age (mean (SD): 57 (35) nmol/l in the youngest group v 123 (89) nmol/l in the elderly group (p<0.001)). There was no difference between the elderly group and Alzheimer patients (115 (62) nmol/l). CSF MMA did not differ in the elderly group and the Alzheimer group (38 (13) v 35 (14) ng/ml). In the youngest group, it was significantly higher (60 (15) ng/ml).Conclusions: CSF total homocysteine is not increased in Alzheimer's disease compared with age matched controls. CSF total homocysteine was correlated with age. The decrease in CSF MMA levels with age eliminates a lack of vitamin B-12 at neuronal level.
ACCESSION #
18972073

 

Related Articles

  • Nephrolithiasis: site of the initial solid phase. Bushinsky, David A. // Journal of Clinical Investigation;3/1/2003, Vol. 111 Issue 5, p602 

    Comments on an article which examined the site of the initial solid phase in nephrolithias. Discussion on the site of the initial solid phase; Mechanisms for stone formation; Description of an animal model of stone formation.

  • Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. Luibl, Volker; Isas, Jose M.; Kayed, Rakez; Glabe, Charles G.; Langen, Ralf; Chen, Jeannie // Journal of Clinical Investigation;Feb2006, Vol. 116 Issue 2, p378 

    Protein misfolding and aggregation are thought to underlie the pathogenesis of many amyloid diseases, such as Alzheimer and Parkinson diseases, whereby a stepwise protein misfolding process begins with the conversion of soluble protein monomers to prefibrillar oligomers and progresses to the...

  • Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. Evan, Andrew P.; Lingeman, James E.; Coe, Fredric L.; Parks, Joan H.; Bledsoe, Sharon B.; Shao, Youzhi; Sommer, Andre J.; Paterson, Ryan F.; Kuo, Ramsay L.; Grynpas, Marc // Journal of Clinical Investigation;3/1/2003, Vol. 111 Issue 5, p607 

    Our purpose here is to test the hypothesis that Randall's plaques, calcium phosphate deposits in kidneys of patients with calcium renal stones, arise in unique anatomical regions of the kidney, their formation conditioned by specific stone-forming pathophysiologies. To test this hypothesis, we...

  • Self-restriction of medications due to cost in seniors without prescription coverage. Steinman, Michael A.; Sands, Laura P.; Covinsky, Kenneth E.; Steinman, M A; Sands, L P; Covinsky, K E // JGIM: Journal of General Internal Medicine;Dec2001, Vol. 16 Issue 12, p793 

    Objective: Little is known about patients who skip doses or otherwise avoid using their medications because of cost. We sought to identify which elderly patients are at highest risk of restricting their medications because of cost, and how prescription coverage modifies this...

  • Assessing Walking Activity in Older Adults: Development and Validation of a Novel Computer-Animated Assessment Tool. Marsh, Anthony P.; Janssen, James A.; Ip, Edward H.; Barnard, Ryan T.; Ambrosius, Walter T.; Brubaker, Peter R.; Burdette, Jonathan H.; Sheedy, Jessica L.; Rejeski, W. Jack // Journals of Gerontology Series A: Biological Sciences & Medical ;Dec2015, Vol. 70 Issue 12, p1555 

    Background: Assessing volume of physical activity (PA) in older adults is critical to understanding the role that PA has on health outcomes and the effectiveness of treatment interventions to increase PA. The purpose of this study was to investigate the psychometric properties of a...

  • Trafficking of immune cells in the central nervous system. Wilson, Emma H.; Weninger, Wolfgang; Hunter, Christopher A. // Journal of Clinical Investigation;May2010, Vol. 120 Issue 5, p1368 

    The CNS is an immune-privileged environment, yet the local control of multiple pathogens is dependent on the ability of immune cells to access and operate within this site. However, inflammation of the distinct anatomical sites (i.e., meninges, cerebrospinal fluid, and parenchyma) associated...

  • CSF Biomarkers for Alzheimer's Disease Diagnosis. Anoop, A.; Singh, Pradeep K.; Jacob, Reeba S.; Maji, Samir K. // International Journal of Alzheimer's Disease;2010, Vol. 2010, p1 

    Alzheimer's disease (AD) is the most common form of dementia that affects several million people worldwide. The major neuropathological hallmarks of AD are the presence of extracellular amyloid plaques that are composed of Aβ40 and Aβ42 and intracellular neurofibrillary tangles (NFT),...

  • Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease. Mattsson, Niklas; Zetterberg, Henrik; Blennow, Kaj // International Journal of Alzheimer's Disease;2010, Vol. 2010, p1 

    Several single-center studies have confirmed the usability of cerebrospinal fluid (CSF) biomarkers for the diagnosis of Alzheimer's disease (AD), even in early disease stages. Large scale multicenter studies have principally confirmed this, although such studies have also indicated the presence...

  • Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. Levites, Yona; Das, Pritam; Price, Robert W.; Rochette, Marjorie J.; Kostura, Lisa A.; McGowan, Eileen M.; Murphy, Michael P.; Golde, Todd E. // Journal of Clinical Investigation;Jan2006, Vol. 116 Issue 1, p193 

    Accumulation and aggregation of amyloid beta peptide 1-42 (Abeta42) in the brain has been hypothesized as triggering a pathological cascade that causes Alzheimer disease (AD). To determine whether selective targeting of Abeta42 versus Abeta40 or total Abeta is an effective way to prevent or...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics